Healthcare -
Biotechnology - NASDAQ - US
$ 8.1
0.621 %
$ 553 M
Market Cap
-4.07
P/E
EYPT - REVENUE
Revenue EYPT - EyePoint Pharmaceuticals, Inc.
46 M
LAST VALUE
11.61%
2 YEAR CAGR
73.10%
5 YEAR CAGR
35.89%
10 YEAR CAGR